MONO PHARMACARE LIMITED

MONOPHARMA

Small Cap | Pharmaceuticals
10.85
+0 (+0%)

Stock price as on 05 Feb 2026 at 13:01 PM

Mono pharmacare limited share price update

As of the latest trading session, Mono Pharmacare Limited share price is currently at ₹10.85, which is up by ₹0 from its previous closing. Today the s...

Mono Pharmacare Limited stock performance

Today’s low

₹10.85

Today’s high

₹10.85

₹10.85

52 week low

₹9.45

52 week high

₹28.9

₹10.85
Open
₹10.85
Previous close
₹10.85
Share volume
6,000
Total traded value (Lakh)
₹0.65
Upper circuit
₹11.35
Lower circuit
₹10.35

Mono Pharmacare Limited fundamentals

Market cap (Cr)
₹19.20
P/E ratio (TTM)
6.2
Book value per share
₹17.65
Beta
0.08
Return on equity
10.42%
Earnings per share (TTM)
₹1.75
Dividend yield
0%
Net profit/quarter (Cr)
₹0.00

Mono Pharmacare Limited financials

(Values in Cr)
Revenue
Net income
(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Revenue

₹82.64

Operating expense

₹81.39

Net income

₹3.09

Net profit margin

3.73%

Earning per share

₹1.75

EBITDA

₹5.09

Effective tax rate

18.03%

Particulars

Mar 24 (₹ value in crores)

Revenue

₹70.72

Operating expense

₹69.55

Net income

₹2.44

Net profit margin

3.45%

Earning per share

₹1.59

EBITDA

₹4.15

Effective tax rate

14.33%

Particulars

Mar 23 (₹ value in crores)

Revenue

₹45.40

Operating expense

₹44.08

Net income

₹1.23

Net profit margin

2.7%

Earning per share

₹1.80

EBITDA

₹2.58

Effective tax rate

21.01%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹17.66

Return on Equity (ROE)

10.49%

Return on Capital Employed (ROCE)

11.01%

Total debt to equity ratio

1.6

EBITDA margin

5.12%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹15.91

Return on Equity (ROE)

11.86%

Return on Capital Employed (ROCE)

10.22%

Total debt to equity ratio

1.97

EBITDA margin

5.25%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹10.82

Return on Equity (ROE)

5.23%

Return on Capital Employed (ROCE)

3.16%

Total debt to equity ratio

3.03

EBITDA margin

6.48%

(Values in Cr)
Revenue
Net income

Particulars (annual)

Mar 25 (₹ value in crores)

Book value per share

₹17.66

Return on Equity (ROE)

10.42%

Return on Capital Employed (ROCE)

10.39%

Total debt to equity ratio

0.62

EBITDA margin

6.17%

Particulars (annual)

Mar 24 (₹ value in crores)

Book value per share

₹15.91

Return on Equity (ROE)

11.76%

Return on Capital Employed (ROCE)

12.06%

Total debt to equity ratio

0.62

EBITDA margin

5.87%

Particulars (annual)

Mar 23 (₹ value in crores)

Book value per share

₹10.83

Return on Equity (ROE)

4.03%

Return on Capital Employed (ROCE)

4.01%

Total debt to equity ratio

0.93

EBITDA margin

7.69%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹0.69

Total assets

₹110.05

Total liabilities

₹110.05

Total equity

₹31.23

Shares outstanding

₹1.76

Price to book ratio

₹1.31

Return on assets (%)

2.8%

Return on capital

3.64%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹0.36

Total assets

₹81.11

Total liabilities

₹81.11

Total equity

₹28.12

Shares outstanding

₹1.76

Price to book ratio

₹2.77

Return on assets (%)

3.01%

Return on capital

3.51%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹0.41

Total assets

₹62.60

Total liabilities

₹62.60

Total equity

₹13.39

Shares outstanding

₹1.23

Price to book ratio

-

Return on assets (%)

1.11%

Return on capital

1.3%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Cash and short term investments

₹0.11

Total assets

₹66.06

Total liabilities

₹66.06

Total equity

₹31.19

Shares outstanding

₹1.76

Price to book ratio

₹1.31

Return on assets (%)

4.67%

Return on capital

5.63%

Particulars

Mar 24 (₹ value in crores)

Cash and short term investments

₹0.25

Total assets

₹45.40

Total liabilities

₹45.40

Total equity

₹28.10

Shares outstanding

₹1.76

Price to book ratio

₹2.77

Return on assets (%)

5.37%

Return on capital

5.9%

Particulars

Mar 23 (₹ value in crores)

Cash and short term investments

₹0.22

Total assets

₹29.06

Total liabilities

₹29.06

Total equity

₹13.39

Shares outstanding

₹1.23

Price to book ratio

-

Return on assets (%)

1.86%

Return on capital

2.09%

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹4.46

Cash from operations

-₹2.91

Cash from investing

-₹0.22

Cash from financing

₹4.86

Net change in cash

₹0.33

Free cash flow

-₹2.68

Particulars

Mar 24 (₹ value in crores)

Net income

₹3.22

Cash from operations

-₹8.04

Cash from investing

₹0.39

Cash from financing

₹8.31

Net change in cash

-₹0.05

Free cash flow

-₹7.86

Particulars

Mar 23 (₹ value in crores)

Net income

₹0.92

Cash from operations

-₹27.75

Cash from investing

-₹1.43

Cash from financing

₹29.60

Net change in cash

₹0.41

Free cash flow

-₹26.89

(Values in Cr)
Revenue
Net income

Particulars

Mar 25 (₹ value in crores)

Net income

₹3.77

Cash from operations

-₹0.01

Cash from investing

-₹7.42

Cash from financing

₹8.01

Net change in cash

-₹0.13

Free cash flow

₹0.16

Particulars

Mar 24 (₹ value in crores)

Net income

₹2.85

Cash from operations

-₹9.94

Cash from investing

-₹1.65

Cash from financing

₹11.99

Net change in cash

₹0.02

Free cash flow

-₹9.91

Particulars

Mar 23 (₹ value in crores)

Net income

₹0.66

Cash from operations

-₹13.31

Cash from investing

-₹2.17

Cash from financing

₹15.89

Net change in cash

₹0.22

Free cash flow

-₹13.10

Mono Pharmacare Limited technical summary

₹10.85
0 ▼
5
Bearish
11
Bullish
5 Day10.3
10 Day10.7
12 Day10.9
20 Day12.1
26 Day12.9
50 Day15.5
100 Day18.9
200 Day23.8
5 Day10.1
10 Day10.2
12 Day10.6
20 Day12
26 Day13
50 Day16.4
100 Day20.2
200 Day23.7

10.85

PIVOT

First support
₹10.85
First resistance
₹10.85
Second support
₹10.85
Second resistance
₹10.85
Third support
₹10.85
Third resistance
₹10.85
RSI
34.73
ADX
63.1
MACD
-1.96
Williams % R
-62.16
Commodity Channel Index (CCI)
-45.95
Date
05 Feb 2026
Same day
6,000
Week
22,000
Month
14,750
1 year
0.08
3 years
0.69
Over 1 month
-21.37%
Over 1 year
-58.26%
Over 3 months
-47.07%
Over 3 years
-29.1%
Over 6 months
-55.07%
Over 6 years
0%

Investment Returns

Over 1 Month21.37%
Over 3 Months47.07%
Over 6 Months55.07%
Over 1 Year58.26%

Mono Pharmacare Limited Shareholding pattern


Public
43.27%
Promoter holdings
56.72%
FII
0%
DII
0%
Promoter shares
0%
Promoter sharesShareCategory

Lakhatariya Panilam

80,26,761 (45.43%)

Shareholding of Promoter and Promoter Group

Supal Panilam Lakhatariya

19,93,458 (11.28%)

Shareholding of Promoter and Promoter Group

Harshad Rasiklal Sheth

6,49,500 (3.68%)

Public Shareholding

Thermo Capital Private Limited

4,12,000 (2.33%)

Public Shareholding

L7 Hitech Private Limited

4,04,000 (2.29%)

Public Shareholding

Promoter sharesShareCategory
Lakhatariya Panilam80,26,761 (45.43%)Shareholding of Promoter and Promoter Group
Supal Panilam Lakhatariya19,93,458 (11.28%)Shareholding of Promoter and Promoter Group
Harshad Rasiklal Sheth6,49,500 (3.68%)Public Shareholding
Thermo Capital Private Limited4,12,000 (2.33%)Public Shareholding
L7 Hitech Private Limited4,04,000 (2.29%)Public Shareholding
Prashil Sanjay Shah3,15,561 (1.79%)Public Shareholding
Yogeshkumar Rasiklal Sanghavi2,88,000 (1.63%)Public Shareholding
Shah Amee T2,25,555 (1.28%)Public Shareholding
Manish Upendra Shanghvi2,24,000 (1.27%)Public Shareholding
Bhawanji Keshavji Chheda2,00,000 (1.13%)Public Shareholding
Shivlal Gandabhai Lakhtaria530 (0%)Shareholding of Promoter and Promoter Group
Pallaviben Suhasbhai Shah530 (0%)Shareholding of Promoter and Promoter Group
Archit Shah530 (0%)Shareholding of Promoter and Promoter Group
Shardaben Shivalal Lakhtaria530 (0%)Shareholding of Promoter and Promoter Group

About MONO PHARMACARE LIMITED

Mono Pharmacare Limited was originally formed as a Partnership Firm in the name and style of 'M/s. Mono Chemist' through Partnership Deed dated May 06, 1994. The Partnership Firm was then converted into Public Limited company in the name of Mono Pharmacare Limited vide Certificate of Incorporation dated October 17, 2022, was issued by the Registrar of Companies, Ahmedabad. The Company is engaged in the business of marketing and distribution of pharmaceutical products. The product portfolio comprises of a wide range of drugs like Antibiotics

Parent Organisation

Indian Private

NSE Symbol

MONOPHARMA

Founded

2022

MONO PHARMACARE LIMITED CORPORATE ACTION

No data available.

View more stocks

What’s trending

All stocks

LOYALTEX

LOYAL TEXTILE MILLS LTD.

304.8
+50.8 (+20%)
GORANIN

GORANI INDUSTRIES LTD.

63.61
+10.6 (+20%)
NIRAJISPAT

NIRAJ ISPAT IND LTD

257.41
+42.9 (+20%)
STRATMONT

STRATMONT INDUSTRIES LIMITED

90.01
+15 (+20%)
View all

Top gainers

ITC

ITC LTD

325.8
+15.60 (+5.03%)
KOTAKBANK

KOTAK MAHINDRA BANK LTD

422.35
+13.60 (+3.33%)
HINDUNILVR

HINDUSTAN UNILEVER LTD.

2424.2
+69.80 (+2.96%)
BHARTIARTL

BHARTI AIRTEL LIMITED

2038.4
+46.00 (+2.31%)
View all

Top losers

HDFCLIFE

HDFC LIFE INS CO LTD

703.5
-17.20 (-2.39%)
TCS

TATA CONSULTANCY SERV LT

2941.6
-49.90 (-1.67%)
TECHM

TECH MAHINDRA LIMITED

1619.9
-26.30 (-1.60%)
BAJAJ-AUTO

BAJAJ AUTO LIMITED

9518.5
-128.50 (-1.33%)
View all

Frequently asked questions


Related videos


Related tags


You are here


Related links

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."


**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer


Powered by Bajaj Financial Securities Limited (Bajaj Broking)